This conference will reflect on the experience gained in the first ten years of the European Orphan Medicinal Products regulation and provide an outlook on future developments. Learning and outcomes from the European Medicines Agency ten year celebration conference on Orphan Medicinal Products will also be shared.
The DIA Future Direction for Orphan Drugs in Europe Conference is immediately preceding the 2nd DIA Health Technology Assessment (HTA) Conference on 4-5 November 2010. The first half day of the HTA Conference continues the disscussion on Orphan Drugs.
Delegates are encouraged to register for both conferences to take advantage of valuable crossover sessions. Benefit from a combined rate and a chance to save up to €600!
Relevant Keywords European Orphan Medicinal Product, Omp Regulation, Orphan Drugs, Market Access, Hta, Orphan Drug Research And Development, Rare Diseases